SCHEMBL3834007

SCHEMBL3834007

CCc1cc(O)c(C(=O)O)cc1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 1/20 0.45
ALOX15 P16050 3/20 0.45
HSD17B10 Q99714 3/20 0.45
MAPT P10636 2/20 0.45
HTT P42858 2/20 0.45
KDM4E B2RXH2 2/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
MAPK1 P28482 1/20 0.45
ALDH1A1 P00352 3/20 0.44
TSHR P16473 2/20 0.44
HPGD P15428 2/20 0.44
RECQL P46063 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
KLKB1 P03952 1/20 0.44
CTSB P07858 1/20 0.44
MMP9 P14780 1/20 0.44
DNMT1 P26358 1/20 0.44
DNMT3B Q9UBC3 1/20 0.44
DNMT3L Q9UJW3 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12553675 0.91 MAPT (0.53) CSNK2A1ALOX15HSD17B10MAPTHTT
SCHEMBL31335625 0.91 MAPT (0.53) CSNK2A1ALOX15HSD17B10MAPTHTT
SCHEMBL3526804 0.89 ALOX15 (0.47) CSNK2A1ALOX15HSD17B10MAPTHTT
SCHEMBL14273018 0.87 GABRP (0.47) CSNK2A1ALOX15HSD17B10MAPTHTT
Alcohol SCHEMBL28690211 0.84 CSNK2A1 (0.50) CSNK2A1ALOX15HSD17B10MAPTHTT
Butane SCHEMBL8165642 0.84 ALDH1A1 (0.54) CSNK2A1ALOX15HSD17B10MAPTHTT
SCHEMBL28184476 0.83 SHBG (0.45) CSNK2A1ALOX15HSD17B10MAPTHTT
SCHEMBL18339211 0.82 TSHR (0.43) CSNK2A1ALOX15HSD17B10ALDH1A1TSHR
Methyl Alcohol SCHEMBL29088014 0.81 CSNK2A1 (0.56) CSNK2A1ALOX15HSD17B10MAPTHTT
SCHEMBL23809736 0.81 ALDH1A1 (0.44) CSNK2A1ALOX15HSD17B10MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5449518-A Bleaching, decoloring skin L'OREAL (FR) 1995-09-12 US claimed
EP-0526302-B1 Depigmentation composition containing derivatives of (2,5-dihydroxyphenyl)-carboxylica OREAL (FR) 1995-03-01 EP claimed
US-8505730-B2 Compositions, kits and regimens for the treatment of skin, especially décolletage JR CHEM, LLC (US) 2013-08-13 US disclosed
US-20120312717-A1 COMPOSITIONS, KITS AND REGIMENS FOR THE TREATMENT OF SKIN, ESPECIALLY DECOLLETAGE JR CHEM, LLC (US) 2012-12-13 US disclosed
US-8273791-B2 Compositions, kits and regimens for the treatment of skin, especially décolletage JR CHEM, LLC (US) 2012-09-25 US disclosed
EP-2087880-A2 Compositions, kits and regimens for the treatment of skin, especially décolletage Jr Chem, LLC (US) 2009-08-12 EP disclosed
US-20090176876-A1 COMPOSITIONS, KITS AND REGIMENS FOR THE TREATMENT OF SKIN, ESPECIALLY DECOLLETAGE JR CHEM, LLC (US) 2009-07-09 US disclosed
US-6960347-B2 Composition based on N-cholesteryloxycarbonyl-4-para-aminophenol and hydroquinone or one of its derivatives L'OREAL (FR) 2005-11-01 US disclosed
US-20010036446-A1 Composition based on N-cholesteryloxycarbonyl-4-para-aminophenol and hydroquinone or one of its derivatives L'OREAL (FR) 2001-11-01 US disclosed
US-5667792-A CARBOXY DERIVATIVES OF HYDROQUINONE AS BLEACHES FOR SKIN L'OREAL (FR) 1997-09-16 US disclosed
US-5637756-A TREATMENT OF SKIN DISORDERS, BLEACHING OF PIGMENTED SPOTS, COSMETICS L'OREAL (FR) 1997-06-10 US disclosed
US-5587173-A Utilization of derivatives of 2,5 dihydroxyphenyl-carboxylic acid amides and their salts in preparation of a cosmetic or dermatological composition with a depigmenting action L'OREAL (FR) 1996-12-24 US disclosed
US-5585105-A Utilization of derivatives of 2,5-dihydroxyphenylcarboxylic acids, their homologs, and their salts in preparation of a cosmetic or dermatological composition with a depigmenting action L'OREAL (FR) 1996-12-17 US disclosed
US-5449518-A Bleaching, decoloring skin L'OREAL (FR) 1995-09-12 US disclosed
US-4245030-A Photopolymerizable mixture containing improved plasticizer HOECHST AKTIENGESELLSCHAFT (DE) 1981-01-13 US disclosed
EP-0006125-A1 Photopolymerisable mixture and light-sensitive coating material HOECHST AKTIENGESELLSCHAFT (DE) 1980-01-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176876-A1 COMPOSITIONS, KITS AND REGIMENS FOR THE TREATMENT OF SKIN, ESPECIALLY DECOLLETAGE RARG, RARA, RXRG CSNK2A1 3717/4885ALOX15 2230/4885HSD17B10 779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.